Connecting novel biological pathways with translational potential and unique small molecules generated/isolated at UC San Diego provides an innovative edge in the discovery of new preclinical agents. These efforts are further strengthened when linked to expertise at UC San Diego spanning multiple areas of scientific endeavor including medicinal chemistry, chemical biology, computational chemistry, and DMPK. With established strengths in translational drug development and agrochemical discovery as well as a long history of excellence in natural product sciences and organic chemistry UC San Diego is accelerating compound development through the UC San Diego Center for Compound Resources (UCCR).
In many instances, initially identified compounds in academia do not advance toward commercial products as additional material is not available or difficult to obtain and the compounds are not optimized for their desired biological function. The UCCR seeks to bridge this need for scientists looking to further advance their projects into human medicine. In addition, the surrounding pharmaceutical industry has continued to cultivate collaborations to improve upon the quality of their chemical inventory as well as access the expertise of the initial isolation and synthesis research groups. The UCCR aims to enable discoveries transitioning from publishable results to commercial applications through the use of compounds, assays, expertise, and facilities at UC San Diego.